New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

Cancer Chemotherapy and Pharmacology Volume 51 Issue 2

2013
- Volume 71
2012
- Volume 70
- Volume 69
2011
- Volume 68
- Volume 67
2010
- Volume 66
- Volume 65
2009
- Volume 65
  - Issue 1 (Dec)
- Volume 64
- Volume 63
2008
- Volume 63
  - Issue 1 (Dec)
- Volume 62
- Volume 61
2007
- Volume 60
- Volume 59
2006
- Volume 58
- Volume 57
2005
- Volume 56
- Volume 55
2004
- Volume 54
- Volume 53
2003
- Volume 52
- Volume 51
2002
- Volume 50
  - Issue 6 (Dec)
  - Issue 5 (Nov)
2001
- Volume 48
  - Issue 5 (Nov)
- Volume 47
  - Issue 1 (Jun)
2000
- Volume 46
- Volume 45
1999
- Volume 44
- Volume 43
1998
- Volume 42
- Volume 41
1997
- Volume 41
- Volume 40
- Volume 39
1989
- Volume 24
  - Issue 2 (Mar)
- Volume 23
1987
- Volume 20
  - Issue 2 (Oct)
  - Issue 1 (Aug)
- Volume 19
1986
- Volume 18
- Volume 16
1985
- Volume 15
1982
- Volume 10
  - Issue 1 (Dec)
1981
- Volume 7
  - Issue 1 (Dec)
- Volume 6
1980
- Volume 4
1979
- Volume 2
1978
- Volume 1

Bookmark
More Like This x1zjJ8ggCk Rentable

A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979)

Sophie, Callies; Dinesh, de Alwis; James, Wright; Alan, Sandler; Michael, Burgess; Leon, Aarons

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This EM9NhRfevC Rentable

Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics

Jan, Maring; Henk, Piersma; Albert, van Dalen; Harry, Groen; Donald, Uges; Elisabeth, De Vries

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This 4a6QnzM00C Rentable

Sonodynamic therapy with photofrin II on AH130 solid tumor

N., Yumita; S., Umemura

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This 2Q33vrFyBF Rentable

Population pharmacokinetics of oxaliplatin

Jean-Pierre, Delord; Amine, Umlil; Rosine, Guimbaud; Nicolas, Grégoire; Thierry, Lafont; Pierre, Canal; Roland, Bugat; Etienne, Chatelut

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This JUwFX8XqRj Rentable

Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens

Kenji, Katsumata; Hidenori, Tomioka; Tetsuo, Sumi; Shinya, Yamashita; Makoto, Takagi; Fumiaki, Kato; Ryuji, Nakamura; Yasuhisa, Koyanagi; Tatsuya, Aoki; Kohichiro, Kato

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This UDOY1N8KES Rentable

Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer

M., Vassilomanolakis; G., Koumakis; S., Drufakou; G., Aperis; M., Demiri; V., Barbounis; J., Missitzis; A., Efremidis

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This ODjwJmL2Xf Rentable

Inhibition of basolateral transport and cellular accumulation of cDDP and N -acetyl- L -cysteine-cDDP by TEA and PAH in the renal proximal tubule

Robert, Kolb; Muhammad, Ghazi; Delon, Barfuss

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This dx9Vg04P5d Rentable

Effect of dexrazoxane on doxorubicin pharmacokinetics in young and old rats

Barry, Cusack; Beth, Musser; Hervé, Gambliel; Nicholas, Hadjokas; Richard, Olson

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This 0p2SdTgciu Rentable

Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells

Wing-Pui, Tsang; Sophia P. Y., Chau; Kwok-Pui, Fung; Siu-Kai, Kong; Tim-Tak, Kwok

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003
Bookmark
More Like This ftNEIol4CS Rentable

Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient

Andrea, Zimmermann; Heinrich, Walt; Urs, Haller; Paul, Baas; Sabine, Klein

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Cancer Chemotherapy and Pharmacology Volume 51 Issue 2

A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979)

Sophie, Callies; Dinesh, de Alwis; James, Wright; Alan, Sandler; Michael, Burgess; Leon, Aarons

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics

Jan, Maring; Henk, Piersma; Albert, van Dalen; Harry, Groen; Donald, Uges; Elisabeth, De Vries

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Sonodynamic therapy with photofrin II on AH130 solid tumor

N., Yumita; S., Umemura

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Population pharmacokinetics of oxaliplatin

Jean-Pierre, Delord; Amine, Umlil; Rosine, Guimbaud; Nicolas, Grégoire; Thierry, Lafont; Pierre, Canal; Roland, Bugat; Etienne, Chatelut

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens

Kenji, Katsumata; Hidenori, Tomioka; Tetsuo, Sumi; Shinya, Yamashita; Makoto, Takagi; Fumiaki, Kato; Ryuji, Nakamura; Yasuhisa, Koyanagi; Tatsuya, Aoki; Kohichiro, Kato

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer

M., Vassilomanolakis; G., Koumakis; S., Drufakou; G., Aperis; M., Demiri; V., Barbounis; J., Missitzis; A., Efremidis

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Inhibition of basolateral transport and cellular accumulation of cDDP and N -acetyl- L -cysteine-cDDP by TEA and PAH in the renal proximal tubule

Robert, Kolb; Muhammad, Ghazi; Delon, Barfuss

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Effect of dexrazoxane on doxorubicin pharmacokinetics in young and old rats

Barry, Cusack; Beth, Musser; Hervé, Gambliel; Nicholas, Hadjokas; Richard, Olson

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells

Wing-Pui, Tsang; Sophia P. Y., Chau; Kwok-Pui, Fung; Siu-Kai, Kong; Tim-Tak, Kwok

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient

Andrea, Zimmermann; Heinrich, Walt; Urs, Haller; Paul, Baas; Sabine, Klein

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Advanced Filters:

Specific Data Sources:

Cancer Chemotherapy and Pharmacology Volume 51 Issue 2

1 - 10 of 12 articles

Sophie, Callies; Dinesh, de Alwis; James, Wright; Alan, Sandler; Michael, Burgess; Leon, Aarons

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Jan, Maring; Henk, Piersma; Albert, van Dalen; Harry, Groen; Donald, Uges; Elisabeth, De Vries

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

N., Yumita; S., Umemura

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Jean-Pierre, Delord; Amine, Umlil; Rosine, Guimbaud; Nicolas, Grégoire; Thierry, Lafont; Pierre, Canal; Roland, Bugat; Etienne, Chatelut

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Kenji, Katsumata; Hidenori, Tomioka; Tetsuo, Sumi; Shinya, Yamashita; Makoto, Takagi; Fumiaki, Kato; Ryuji, Nakamura; Yasuhisa, Koyanagi; Tatsuya, Aoki; Kohichiro, Kato

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

M., Vassilomanolakis; G., Koumakis; S., Drufakou; G., Aperis; M., Demiri; V., Barbounis; J., Missitzis; A., Efremidis

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Robert, Kolb; Muhammad, Ghazi; Delon, Barfuss

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Barry, Cusack; Beth, Musser; Hervé, Gambliel; Nicholas, Hadjokas; Richard, Olson

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Wing-Pui, Tsang; Sophia P. Y., Chau; Kwok-Pui, Fung; Siu-Kai, Kong; Tim-Tak, Kwok

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003

Andrea, Zimmermann; Heinrich, Walt; Urs, Haller; Paul, Baas; Sabine, Klein

Follow Cancer Chemotherapy and Pharmacology , Volume 51 (2) Springer Journals – Feb 1, 2003